|
|
|
|
|
 HTML
PDF |
|
Murphy S, Anderson L, Johnston B, Fitzpatrick D, Watson P, Monaghan P, Murray L.Have patients with esophagitis got an increased risk of adenocarcinoma? Results from a population-based study.
World J Gastroenterol 2005 December;11(46):7290-7295
Have patients with esophagitis got an increased risk of adenocarcinoma? Results from a population-based study
Murphy S, Anderson L, Johnston B, Fitzpatrick D, Watson P, Monaghan P, Murray L.
Department of Epidemiology and Public Health, Mulhouse Building, Grosvenor Road, Belfast BT12 6BJ, Northern Ireland. s.murphy@qub.ac.uk
AIM:To examine an increased risk of esophageal adenocarcinoma is restricted to patients who develop Barrett's esophagus or whether esophagitis per se is a risk factor for adenocarcinoma.METHODS: A population-based cohort of patients with histological evidence of esophagitis without Barrett's esophagus was constructed using electronic pathology reports relating to all esophageal biopsies in Northern Ireland between 1993 and 1996. Person-years of follow-up and incident cases of esophageal cancer were calculated by linking the cohort to death files and the Northern Ireland Cancer Registry records. Standardized incidence ratios (SIR) were calculated for esophageal cancers (adenocarcinoma, squamous cell carcinoma (SCC), and histologically unspecified cancers).RESULTS: A total of 2 013 patients in the cohort provided 13 559 patient-years of follow-up (mean follow-up 6.7 years). None of the patients developed adenocarcinoma. Three patients developed SCC, and six developed histologically unspecified cancers. The SIR for all esophageal cancers and for SCC were 2.73 (95%CI 1.25-5.19) and 2.93 (95%CI 0.61-8.59), respectively. In a sensitivity analysis in which all unspecified esophageal cancers were treated as adenocarcinomas, the SIR for adenocarcinoma was 2.64 (0.97-5.75).CONCLUSION: The risk of adenocarcinoma is not elevated in patients with histological evidence of esophagitis without Barrett's esophagus; however, these patients may have a moderately increased risk of SCC. Further studies are required to confirm these findings, which suggest that Barrett's esophagus, not esophagitis, is the key precursor lesion in the development of adenocarcinoma. |
|
|
|
The WJG Press, Room 1066, Yishou Garden ,
No. 58, North Langxinzhuang Road,
PO Box 2345, Beijing 100023, China
Fax: +86-10-85381893
Telephone: +86-10-85381892
E-mail: wjg@wjgnet.com
http: // www.wjgnet.com
Copyright 2004-2007 by The WJG Press and Beijing Baishideng BioMed Technology Co., Ltd.
| |
Editorial Board
